
    
      To compare the plasma levels of dronabinol (delta-9-tetrahydrocannabinol)and the principle
      active metabolite 11-OH-delta-9-tetrahydrocannabinol levels produced after administration of
      the test formulation with those produced after administration of a marketed reference
      product, under fasted conditions.
    
  